Share:
Peer-Reviewed Publication
Med Phys2024;51(2):712-739.February 1, 2024Journal Article

Joint AAPM Task Group 282/EFOMP Working Group Report: Breast dosimetry for standard and contrast-enhanced mammography and breast tomosynthesis.

Ioannis Sechopoulos1,2,3, David R Dance4, John M Boone5, Hilde T Bosmans6, Marco Caballo1, Oliver Diaz7, Ruben van Engen2, Christian Fedon8, Stephen J Glick9, Andrew M Hernandez5, Melissa L Hill10, Katie W Hulme11, Renata Longo12, Carolina Rabin13, Wendelien B G Sanderink1, J Anthony Seibert5
1Radboud University Medical Center, Nijmegen, The Netherlands.
2Dutch Expert Centre for Screening (LRCB), Nijmegen, The Netherlands.
3University of Twente, Enschede, The Netherlands.
4National Co-ordinating Centre for the Physics of Mammography (NCCPM), Royal Surrey County Hospital, Guildford, UK.
5University of California, Davis, California, USA.
6KU Leuven, Leuven, Belgium.
7University of Barcelona, Barcelona, Spain.
8Radboud University Medical Center (now at Nuclear Research and Consultancy Group, NRG), Nijmegen, The Netherlands.
9Food and Drug Administration, Silver Spring, USA.
10Volpara Health, Wellington, New Zealand.
11Cleveland Clinic, Beachwood, USA.
12University of Trieste, Trieste, Italy.
13University of the Republic, Montevideo, Uruguay.

Abstract

Currently, there are multiple breast dosimetry estimation methods for mammography and its variants in use throughout the world. This fact alone introduces uncertainty, since it is often impossible to distinguish which model is internally used by a specific imaging system. In addition, all current models are hampered by various limitations, in terms of overly simplified models of the breast and its…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.